Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement.
NAFLD/NASH
hepatocellular carcinoma
magnetic resonance elastography
ultrasound elastography
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
19 Jan 2023
19 Jan 2023
Historique:
received:
30
12
2022
revised:
17
01
2023
accepted:
18
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
Nonalcoholic fatty liver disease (NAFLD), which is nowadays the most common etiology of chronic liver disease, is associated with an increased risk of hepatocellular carcinoma (HCC), with or without cirrhosis. Owing to the high prevalence of NAFLD worldwide, it becomes crucial to develop adequate strategies for surveillance of HCC and new prediction models aiming at stratifying NAFLD population for HCC risk. To this purpose, several noninvasive tests (NITs) have been proposed in the several last years, including clinical parameters, serum biomarkers, and imaging techniques. Most of these tools are focused on the assessment of liver fibrosis. Both ultrasound (US) elastography (especially transient elastography) and magnetic resonance (MR) elastography have been evaluated to estimate HCC risk in NAFLD patients. Recently, the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) include these techniques among the recommended NITs for the assessment of liver fibrosis. The aim of this review is to summarize the most recent data on the role of US and MR elastography in HCC risk stratification in patients with NAFLD.
Identifiants
pubmed: 36765595
pii: cancers15030637
doi: 10.3390/cancers15030637
pmc: PMC9913338
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cell Metab. 2022 Jul 5;34(7):969-977.e2
pubmed: 35793659
Gut. 2023 Jan;72(1):141-152
pubmed: 34933916
Am J Gastroenterol. 2017 Dec;112(12):1812-1823
pubmed: 29087391
Yonago Acta Med. 2017 Jun 26;60(2):106-112
pubmed: 28701893
World J Gastrointest Pathophysiol. 2022 May 22;13(3):96-106
pubmed: 35720167
Ultrasound Med Biol. 2003 Dec;29(12):1705-13
pubmed: 14698338
Gastroenterology. 2016 Mar;150(3):626-637.e7
pubmed: 26677985
J Hepatol. 2017 Nov 02;:
pubmed: 29150142
Hepatology. 2015 May;61(5):1547-54
pubmed: 25125077
Aliment Pharmacol Ther. 2011 Jul;34(1):83-91
pubmed: 21535445
JHEP Rep. 2021 Jan 19;3(2):100231
pubmed: 33748726
Hepatology. 2021 Nov;74(5):2410-2423
pubmed: 33811766
Abdom Radiol (NY). 2022 Nov;47(11):3733-3745
pubmed: 35962809
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861
pubmed: 35798021
Radiology. 2017 May;283(2):418-428
pubmed: 27861111
Liver Int. 2015 Mar;35(3):1054-62
pubmed: 24930484
Hepatology. 2018 Aug;68(2):723-750
pubmed: 29624699
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428
pubmed: 31028350
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Sci Rep. 2022 Jan 27;12(1):1449
pubmed: 35087141
Int J Cancer. 2011 May 15;128(10):2436-43
pubmed: 21128245
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238
pubmed: 33349658
Gastroenterology. 2020 May;158(7):1999-2014.e1
pubmed: 32044314
Hepatology. 2017 Nov;66(5):1486-1501
pubmed: 28586172
Mol Clin Oncol. 2016 Apr;4(4):587-590
pubmed: 27073669
Mayo Clin Proc. 2016 Mar;91(3):329-35
pubmed: 26837481
Eur Radiol. 2019 Feb;29(2):1013-1021
pubmed: 30043162
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Hepatology. 2021 Jan;73 Suppl 1:4-13
pubmed: 32319693
J Gastroenterol Hepatol. 2018 Feb;33(2):503-510
pubmed: 28666070
Clin Gastroenterol Hepatol. 2016 Jan;14(1):124-31.e1
pubmed: 26196445
Liver Int. 2023 Jan;43(1):90-99
pubmed: 36050821
J Med Ultrason (2001). 2022 Apr;49(2):253-259
pubmed: 35129720
Ultrasound Med Biol. 2009 Feb;35(2):219-29
pubmed: 19081665
Clin Transl Gastroenterol. 2021 Apr 23;12(4):e00337
pubmed: 33888672
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2
pubmed: 23041539
J Hepatol. 2021 Sep;75(3):659-689
pubmed: 34166721
Hepatol Res. 2019 Oct;49(10):1207-1217
pubmed: 31219667
Hepatology. 2011 Mar;53(3):885-94
pubmed: 21319193
Clin Gastroenterol Hepatol. 2019 Mar;17(4):630-637.e8
pubmed: 29908362
Aliment Pharmacol Ther. 2022 Feb;55(3):292-301
pubmed: 34927277
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Liver Int. 2020 Mar;40(3):581-589
pubmed: 31749300
Science. 1995 Sep 29;269(5232):1854-7
pubmed: 7569924
J Hepatol. 2021 Oct;75(4):770-785
pubmed: 33991635
Ultrasound Med Biol. 2002 Feb;28(2):227-35
pubmed: 11937286
Gastroenterology. 2022 Oct;163(4):1079-1089.e5
pubmed: 35788349
J Hepatol. 2011 Jan;54(1):160-3
pubmed: 20934232
Exp Biol Med (Maywood). 2020 Jan;245(2):96-108
pubmed: 31924111
Curr Med Res Opin. 2010 Sep;26(9):2183-91
pubmed: 20666689
Clin Gastroenterol Hepatol. 2021 Apr;19(4):806-815.e5
pubmed: 32621970
Gastroenterology. 2017 Feb;152(3):598-607.e2
pubmed: 27911262
Cancers (Basel). 2021 Sep 11;13(18):
pubmed: 34572795
Ann Med. 2011 Dec;43(8):617-49
pubmed: 21039302
Ultrasound Med Biol. 2010 Nov;36(11):1825-35
pubmed: 20870345
J Clin Gastroenterol. 2008 Aug;42(7):839-43
pubmed: 18668703
Hepatology. 2023 Jan 1;77(1):323-338
pubmed: 35478412
Hepatology. 2016 Mar;63(3):827-38
pubmed: 26599351
Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):361-374
pubmed: 30791772